Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Federico Galvagni is working in Dipartimento di Biotecnologie, Chimica e Farmacia Università di Siena and interested in development of stem cell therapy.
Study of VEGF angiogenic factors and their receptors,Transcriptional regulation of the human Utrophin gene for the Duchenne muscular dystrophy therapy, Mutation analysis of the human Dystrophin gene.
Francesco Neri, Caterina De Clemente, Maurizio Orlandini, Claudia Lentucci, Francesca Anselmi and Federico Galvagni
Research Article: J Stem Cell Res Ther 2015, 5:293